Anzeige
Mehr »
Freitag, 29.08.2025 - Börsentäglich über 12.000 News
Megatrend Uran: Die Nachfrage nach Uran explodiert - greift jetzt Buffetts Erfolgsrezept?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
29.08.25 | 15:37
150,00 Euro
+0,10 % +0,15
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
151,65152,2520:51
151,65152,2520:51

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiICON PLC - 6-K, Report of foreign issuer1
ICON Aktie jetzt für 0€ handeln
13.08.ICON suspends COVID vaccine study after BARDA notice5
12.08.ICON PLC - 6-K, Report of foreign issuer1
30.07.Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-0017
29.07.Hoth Therapeutics, Inc.: Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe190The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 /PRNewswire/...
► Artikel lesen
24.07.ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery7
23.07.ICON Plc Q2 Profit Climbs10
23.07.ICON PLC - 6-K, Report of foreign issuer1
23.07.ICON plc: ICON Announces Results of Annual General Meeting237ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced that all resolutions at the Annual General Meeting of the company (AGM)...
► Artikel lesen
23.07.ICON plc: ICON Reports Second Quarter 2025 Results318Highlights Gross business wins in the quarter of $2,966 million, representing an increase of 10.6% on quarter one 2025. Net business wins in the quarter of $2,057 million; a net book...
► Artikel lesen
16.07.ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report626ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1...
► Artikel lesen
15.07.Do You Believe in the Upside Potential of ICON PLC (ICLR)?24
09.07.ICON plc stock price target lowered to $187 at Truist Securities7
07.07.ICON plc: ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability370ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the...
► Artikel lesen
26.06.Should You Hold ICON PLC (ICLR)?16
23.06.ICON plc Schedules Second Quarter 2025 Earnings Conference Call313ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025...
► Artikel lesen
18.06.ICON PLC - 6-K, Report of foreign issuer1
11.06.ICON PLC - 6-K, Report of foreign issuer2
02.06.Here's Why You Should Retain ICLR Stock in Your Portfolio Now19
27.05.ICON plc wird auf der jährlichen Growth Stock Konferenz präsentieren10
Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1